- Home
- JCSE vs NCNA Comparison
JCSE vs NCNA Comparison
Compare JCSE & NCNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JCSE
- NCNA
- Stock Information
- Founded
- JCSE 1999
- NCNA 1997
- Country
- JCSE Singapore
- NCNA United Kingdom
- Employees
- JCSE N/A
- NCNA N/A
- Industry
- JCSE Miscellaneous manufacturing industries
- NCNA Biotechnology: Pharmaceutical Preparations
- Sector
- JCSE Consumer Discretionary
- NCNA Health Care
- Exchange
- JCSE Nasdaq
- NCNA Nasdaq
- Market Cap
- JCSE 5.9M
- NCNA 6.6M
- IPO Year
- JCSE 2022
- NCNA 2017
- Fundamental
- Price
- JCSE $1.07
- NCNA $2.87
- Analyst Decision
- JCSE
- NCNA
- Analyst Count
- JCSE 0
- NCNA 0
- Target Price
- JCSE N/A
- NCNA N/A
- AVG Volume (30 Days)
- JCSE 60.5K
- NCNA 483.1K
- Earning Date
- JCSE 10-29-2025
- NCNA 08-20-2025
- Dividend Yield
- JCSE 8.53%
- NCNA N/A
- EPS Growth
- JCSE N/A
- NCNA N/A
- EPS
- JCSE 0.00
- NCNA N/A
- Revenue
- JCSE $14,126,397.00
- NCNA N/A
- Revenue This Year
- JCSE N/A
- NCNA N/A
- Revenue Next Year
- JCSE N/A
- NCNA N/A
- P/E Ratio
- JCSE $229.49
- NCNA N/A
- Revenue Growth
- JCSE 6.92
- NCNA N/A
- 52 Week Low
- JCSE $0.86
- NCNA $2.78
- 52 Week High
- JCSE $2.39
- NCNA $1,650.00
- Technical
- Relative Strength Index (RSI)
- JCSE 60.52
- NCNA 29.04
- Support Level
- JCSE $0.90
- NCNA $2.78
- Resistance Level
- JCSE $1.28
- NCNA $3.60
- Average True Range (ATR)
- JCSE 0.07
- NCNA 0.28
- MACD
- JCSE 0.02
- NCNA 0.32
- Stochastic Oscillator
- JCSE 45.29
- NCNA 7.20
About JCSE JE Cleantech Holdings Limited
JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.
About NCNA NuCana plc
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.